Low prevalence of bisphosphonate therapy among long-term glucocorticoid users.

被引：0
|
作者：
Anthony, M.
Stephenson, J. J.
Long, S.
Lin, S. L.
机构：
[1] Amgen Inc, Thousand Oaks, CA USA
[2] Thomson Medstat, Ann Arbor, MI USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S281 / S281
页数：1
相关论文
共 50 条
  • [1] Improving quality of osteoporosis care for long term glucocorticoid users.
    Curtis, J. R.
    Westfall, A. O.
    Allison, J. J.
    Becker, A.
    MacArthur, M.
    Ockershausen, T.
    Stewart, E.
    Weissman, N.
    Saag, K. G.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S420 - S420
  • [2] Challenges in improving quality of osteoporosis care for long term glucocorticoid users.
    Curtis, Jeffrey R.
    Westfall, Andrew O.
    Allison, Jeroan J.
    Becker, Angela
    MacArthur, Marilyn
    Ockerhurst, Theresa
    Stewart, Emily
    Weissman, Norman
    Saag, Kenneth G.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S85 - S85
  • [3] Nationwide prevalence of glucocorticoid prescriptions over 17 years and osteoporosis prevention among long-term users
    Bjornsdottir, Hulda Hrund
    Einarsson, olafur Brynjolfur
    Grondal, Gerdur
    Gudbjornsson, Bjorn
    SAGE OPEN MEDICINE, 2024, 12
  • [4] Long-term risks of bisphosphonate therapy
    Watts, Nelson B.
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2014, 58 (05) : 523 - 529
  • [5] Risks and benefits of long-term bisphosphonate therapy
    Schmidt, Ginelle A.
    Horner, Kathleen E.
    McDanel, Deanna L.
    Ross, Mary B.
    Moores, Kevin G.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (12) : 994 - 1001
  • [6] Long-Term Bisphosphonate Therapy in Osteogenesis Imperfecta
    Biggin, A.
    Munns, C. F.
    CURRENT OSTEOPOROSIS REPORTS, 2017, 15 (05): : 412 - 418
  • [7] Long-Term Bisphosphonate Therapy in Osteogenesis Imperfecta
    A. Biggin
    C. F. Munns
    Current Osteoporosis Reports, 2017, 15 : 412 - 418
  • [8] Minimal hepatic fibrosis in long-term active injection drug users.
    Dove, LM
    Seal, K
    McNees, A
    Herndier, B
    Wright, TL
    Edlin, B
    HEPATOLOGY, 2002, 36 (04) : 350A - 350A
  • [9] Persistence and adherence to alendronate and risedronate among chronic glucocorticoid users.
    Curtis, JR
    Westfall, AO
    Allison, JJ
    Kiefe, CI
    Saag, KG
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S279 - S279
  • [10] Is long-term glucocorticoid therapy associated with a high prevalence of asymptomatic vertebral fractures?
    Weinstein, Robert S.
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2007, 3 (02): : 86 - 87
12345